Year: 2020
Resolution Number: 47
Action Taken: Approved
Status: In Progress
Author(s): Jennifer Asante, Connor Buechler, May Chammaa, Jody Chou, Emily Currier, Peter Dimitrion, Preetha Ghosh, Aileen Haque, Ashton Lewandowski, Michael Moentmann, Tabitha Moses, Dhruvil Patel, Mauli Patel, Brianna Sohl, Shabber Syed, and Suha Syed
Sponsor: Nabiha Hashmi
On behalf of: Medical Student Section
Committee: B (Legislation)
Resolved Section(s):
RESOLVED: That MSMS advocate for the availability of all types of opioid agonist treatment for opioid use disorder for incarcerated persons in Michigan; and be it furtherRESOLVED: That MSMS encourage correctional facilities to use a validated screening tool to identify withdrawal and determine potential need for treatment for opioid use disorder for all incarcerated persons upon entry; and be it furtherRESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to amend H-430.987 Opiate Replacement Therapy Programs in Correctional Facilities by addition as follows:H-430.987 Opiate Replacement Therapy Programs in Correctional Facilities1. Our AMA endorses: (a) the medical treatment model of employing opiate replacement therapy (ORT) as an effective therapy in treating opiate-addicted persons who are incarcerated; and (b) ORT for opiate-addicted persons who are incarcerated, in collaboration with the National Commission on Correctional Health Care and the American Society of Addiction Medicine. 2. Our AMA advocates for legislation, standards, policies and funding that encourage correctional facilities to increase access to evidence-based treatment of opioid use disorder, including initiation and continuation of opioid replacement therapy in conjunction with counseling, in correctional facilities within the United States and that this apply to all incarcerated individuals including pregnant women. 3. Our AMA supports legislation, standards, policies, and funding that encourage correctional facilities within the United States to work in ongoing collaboration with addiction treatment physician-led teams, case managers, social workers, and pharmacies in the communities where patients, including pregnant women, are released to offer post-incarceration treatment plans for opioid use disorder, including education, medication for addiction treatment and counseling, and medication for preventing overdose deaths and help ensure post-incarceration medical coverage and accessibility to medication assisted therapy. 4. Our AMA encourages all correctional facilities to use a validated screening tool to identify withdrawal and determine potential need for treatment for opioid use disorder for all incarcerated persons upon entry.
RESOLVED: That MSMS advocate for the availability of all types of opioid agonist treatment for opioid use disorder for incarcerated persons in Michigan; and be it furtherRESOLVED: That MSMS encourage correctional facilities to use a validated screening tool to identify withdrawal and determine potential need for treatment for opioid use disorder for all incarcerated persons upon entry; and be it furtherRESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to amend H-430.987 Opiate Replacement Therapy Programs in Correctional Facilities by addition as follows:H-430.987 Opiate Replacement Therapy Programs in Correctional Facilities1. Our AMA endorses: (a) the medical treatment model of employing opiate replacement therapy (ORT) as an effective therapy in treating opiate-addicted persons who are incarcerated; and (b) ORT for opiate-addicted persons who are incarcerated, in collaboration with the National Commission on Correctional Health Care and the American Society of Addiction Medicine. 2. Our AMA advocates for legislation, standards, policies and funding that encourage correctional facilities to increase access to evidence-based treatment of opioid use disorder, including initiation and continuation of opioid replacement therapy in conjunction with counseling, in correctional facilities within the United States and that this apply to all incarcerated individuals including pregnant women. 3. Our AMA supports legislation, standards, policies, and funding that encourage correctional facilities within the United States to work in ongoing collaboration with addiction treatment physician-led teams, case managers, social workers, and pharmacies in the communities where patients, including pregnant women, are released to offer post-incarceration treatment plans for opioid use disorder, including education, medication for addiction treatment and counseling, and medication for preventing overdose deaths and help ensure post-incarceration medical coverage and accessibility to medication assisted therapy. 4. Our AMA encourages all correctional facilities to use a validated screening tool to identify withdrawal and determine potential need for treatment for opioid use disorder for all incarcerated persons upon entry.
Fiscal Note: At least $500
For More Information, Contact: